Phase 3 Trial Evaluating the Efficacy and Safety of Cytisinicline for Vaping Cessation in Adults Using Nicotine-Containing E Cigarettes
Study sponsor: Achieve Life Sciences
Primary completion is the date data collection ends for the main study measures, not when results are published.
Primary completion2026-11-15Estimated
Enrollment · participants800Estimated
Source updated2026-02-06Last update listed in the registry record
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.